Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Duration: 48 months, Funding volume: € 899,099
Improvement of taste perception by homoeriodictyol in cancer patients after chemotherapy
Duration: 60 months, Funding volume: € 362,540
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Duration: 60 months, Funding volume: € 799,350
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
Duration: 48 months, Funding volume: € 799,510